Cargando…

Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model

Detalles Bibliográficos
Autores principales:	Chai, Sanbao, Yu, Shuqing, Liu, Fengqi, Liu, Zuoxiang, Yang, Qingqing, Sun, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106192/ https://www.ncbi.nlm.nih.gov/pubmed/36723862 http://dx.doi.org/10.1097/CM9.0000000000002520

Ejemplares similares

Cognitive protection of incretin‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies
por: Chai, Sanbao, et al.
Publicado: (2023)

Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks
por: Chai, Sanbao, et al.
Publicado: (2022)

Neurological Manifestation of Incretin-Based Therapies in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
por: Gao, Le, et al.
Publicado: (2019)

Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
por: Chai, Sanbao, et al.
Publicado: (2019)

Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
por: Drucker, Daniel J., et al.
Publicado: (2010)

Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
por: Wibawa, I Dewa Nyoman, et al.
Publicado: (2023)

Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Incretin action on bone: An added benefit?
por: Ma, Ronald C W, et al.
Publicado: (2015)

Comment on “New therapeutic agents in diabetic nephropathy”
por: Gay, Alain, et al.
Publicado: (2017)

Multicriteria optimization
por: Ehrgott, Matthias, et al.
Publicado: (2000)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Response to comment on “New therapeutic agents in diabetic nephropathy”
por: Kim, Yaeni, et al.
Publicado: (2017)

A Method to Dynamic Stochastic Multicriteria Decision Making with Log-Normally Distributed Random Variables
por: Wang, Xin-Fan, et al.
Publicado: (2013)

The Influence of Incretin Mimetics on Cardiovascular Risk Factors in Diabetes
por: Kinalska, Ida, et al.
Publicado: (2012)

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
por: Mima, Akira
Publicado: (2016)

Incretin Learning and Excellence Academy for Diabetes (iLEAD)
por: Bajaj, Sarita, et al.
Publicado: (2016)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
por: Kang, Yu Mi, et al.
Publicado: (2017)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Incretins and cardiovascular disease: to the heart of type 2 diabetes?
por: Solini, Anna, et al.
Publicado: (2023)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

Advances in multicriteria analysis
por: Pardalos, Panos, et al.
Publicado: (1995)

Multicriteria optimization and engineering
por: Statnikov, Roman B, et al.
Publicado: (1995)

Multicriteria Portfolio Management
por: Xidonas, Panos, et al.
Publicado: (2012)

Handbook of Multicriteria Analysis
por: Zopounidis, Constantin, et al.
Publicado: (2010)

The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)

Incretin response in Asian type 2 diabetes: Are Indians different?
por: Singh, Awadhesh Kumar
Publicado: (2015)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus
por: Pilszyk, Aleksandra, et al.
Publicado: (2022)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

What Are Incretins, and How Will They Influence the Management of Type 2 Diabetes?
por: Bonde, Lawrence, et al.
Publicado: (2006)

Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy
por: Goldney, Jonathan, et al.
Publicado: (2023)

Incretin-based therapies for patients with type 1 diabetes: a meta-analysis
por: Liu, Lili, et al.
Publicado: (2019)

Association Between Different Parameters of Adipose Distribution and Transient Elastography-Assessed Hepatic Steatosis in American Adults with Diabetes, Prediabetes and Normal Glucose Tolerance
por: Liu, Yufang, et al.
Publicado: (2023)

Right ventricule-specific therapies in ARDS: other vasodilating agents to be considered
por: Ymeraj, Senada, et al.
Publicado: (2023)

Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
por: Xie, Yaochen, et al.
Publicado: (2023)

Effects of incretin-based therapies on β-cell function in type 1 diabetes mellitus: a systematic review and meta-analysis
por: Wu, Yucheng, et al.
Publicado: (2021)

In vitro Activity of Different Antibacterial Agents in Combination with Each Other against Multidrug-resistant Acinetobacter baumannii
por: Wang, Feng-Juan, et al.
Publicado: (2016)

Multicriteria optimization in engineering and in the sciences
por: Stadler, Wolfram
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_u2hi1e650h5lghe9qptrb1smop